Leap Therapeutics, Inc. slid in premarket trading on Thursday after unveiling significant corporate changes and a large at-the-market equity plan.
The biotechnology company is rebranding as Cypherpunk Technologies Inc. to pivot toward a digital-asset-focused strategy, per a press release issued yesterday.
The company stated that it is adopting the Cypherpunk name and shifting to a digital-asset treasury anchored in Zcash. The ticker will change from LPTX to CYPH on Nov. 13, 2025, following the rebrand and adoption of the digital-asset treasury strategy.
Also Read: Government Shutdown Over—But Bitcoin Remains In ‘Extreme Fear’ At $103,000
Leadership said it has already deployed $50 million to acquire more than 203,000 ZEC at an average price of $245 each. The stock will begin trading under the ticker CYPH on Thursday as part of the transition.
Meanwhile, on Thursday, Leap Therapeutics detailed a new sales agreement that allows it to sell up to $200 million in stock through Cantor Fitzgerald. The firm disclosed terms of the arrangement in its latest filing, marking another step in its strategic overhaul.
The company, which posted a narrower third-quarter loss on Wednesday, reported an eight-cent-per-share loss. It also sharply reduced its net loss from a year earlier after cutting research, development and administrative expenses.
Cash stood at nearly $10 million at the end of September, excluding funds from a recent private placement.
The firm appointed Khing Oei as chairman and added Will McEvoy as its first chief investment officer. Both joined the board this week following the company's $58.88 million private placement led solely by Winklevoss Capital.
Executives described the digital-asset strategy as a long-term effort centered on privacy and shareholder value.
Price Action: LPTX shares are trading 23.9% lower at $1.55 premarket at last check on Thursday.
Read Next:
From Azure Darling To Momentum Dog: C3.ai's Plunging Score Signals Partner Risk